Arizona State Retirement System boosted its stake in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) by 225.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 106,839 shares of the life sciences company’s stock after acquiring an additional 74,045 shares during the period. Arizona State Retirement System’s holdings in Integra Lifesciences were worth $5,113,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently made changes to their positions in IART. Whittier Trust Co. acquired a new position in shares of Integra Lifesciences during the third quarter worth approximately $169,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Integra Lifesciences by 38.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,806 shares of the life sciences company’s stock worth $182,000 after buying an additional 1,054 shares during the last quarter. Zions Bancorporation acquired a new position in shares of Integra Lifesciences during the third quarter worth approximately $205,000. Ameritas Investment Partners Inc. lifted its holdings in shares of Integra Lifesciences by 3.6% during the second quarter. Ameritas Investment Partners Inc. now owns 5,409 shares of the life sciences company’s stock worth $295,000 after buying an additional 187 shares during the last quarter. Finally, Campbell Newman Asset Management Inc. lifted its holdings in shares of Integra Lifesciences by 21.5% during the fourth quarter. Campbell Newman Asset Management Inc. now owns 6,964 shares of the life sciences company’s stock worth $333,000 after buying an additional 1,234 shares during the last quarter. 86.39% of the stock is owned by hedge funds and other institutional investors.
Integra Lifesciences Holdings Corp (NASDAQ IART) opened at $54.07 on Friday. The company has a debt-to-equity ratio of 1.26, a current ratio of 4.49 and a quick ratio of 3.39. The company has a market capitalization of $4,153.81, a price-to-earnings ratio of 88.64, a P/E/G ratio of 1.69 and a beta of 0.67. Integra Lifesciences Holdings Corp has a 12 month low of $40.51 and a 12 month high of $56.42.
IART has been the subject of a number of research analyst reports. Zacks Investment Research upgraded Integra Lifesciences from a “sell” rating to a “hold” rating in a report on Tuesday, December 26th. Oppenheimer set a $58.00 price target on Integra Lifesciences and gave the stock a “buy” rating in a report on Tuesday, December 12th. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price target on shares of Integra Lifesciences in a report on Friday, January 5th. TheStreet upgraded Integra Lifesciences from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Finally, Bank of America lowered Integra Lifesciences from a “buy” rating to a “neutral” rating in a report on Tuesday, January 2nd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. Integra Lifesciences presently has a consensus rating of “Hold” and a consensus target price of $52.70.
WARNING: “Integra Lifesciences Holdings Corp (IART) Holdings Raised by Arizona State Retirement System” was first posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://transcriptdaily.com/2018/02/25/integra-lifesciences-holdings-corp-iart-holdings-raised-by-arizona-state-retirement-system.html.
Integra Lifesciences Company Profile
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions.
Want to see what other hedge funds are holding IART? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integra Lifesciences Holdings Corp (NASDAQ:IART).
Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.